Skip to main content
Top
Published in: Netherlands Heart Journal 9/2017

Open Access 01-09-2017 | Original Article

Thirty years of heart transplantation at the University Medical Centre Utrecht

Authors: A. Sammani, A. M. Wind, J. H. Kirkels, C. Klöpping, M. P. Buijsrogge, F. Z. Ramjakhan, F. W. Asselbergs, N. de Jonge

Published in: Netherlands Heart Journal | Issue 9/2017

Login to get access

Abstract

Purpose

To analyse patient demographics, indications, survival and donor characteristics for heart transplantation (HTx) during the past 30 years at the University Medical Centre Utrecht (UMCU).

Methods

Data have been prospectively collected for all patients who underwent HTx at the UMCU from 1985 until 2015. Patients who were included underwent orthotopic HTx at an age >14 years.

Results

In total, 489 hearts have been transplanted since 1985; 120 patients (25%) had left ventricular assist device (LVAD) implantation prior to HTx. A shift from ischaemic heart disease to dilated cardiomyopathy has been seen as the leading indication for HTx since the year 2000. Median age at HTx was 49 years (range 16–68). Median waiting time and donor age have also increased from 40 to 513 days and from 27 to 44 years respectively (range 11–65). Donor cause of death is now primarily stroke, in contrast to head and brain injury in earlier years. Estimated median survival is 15.4 years (95% confidence interval 14.2–16.6) There is better survival throughout these years.

Conclusion

Over the past 30 years, patient and donor demographics and underlying diseases have shifted substantially. Furthermore, the increase in waiting time due to lack of available donor hearts has led to a rise in the use of LVADs as bridge to transplant. Importantly, an improvement in survival rates is found over time which could be explained by better immunosuppressive therapy and improvements in follow-up care.
Literature
1.
go back to reference Lund LH, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second official adult heart transplantation report – 2015; focus theme: early graft failure. J Heart Lung Transplant. 2015;34:1244–54.CrossRefPubMed Lund LH, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second official adult heart transplantation report – 2015; focus theme: early graft failure. J Heart Lung Transplant. 2015;34:1244–54.CrossRefPubMed
2.
go back to reference Hunt SA. Taking heart – cardiac transplantation past, present, and future. N Engl J Med. 2006;355:231–5.CrossRefPubMed Hunt SA. Taking heart – cardiac transplantation past, present, and future. N Engl J Med. 2006;355:231–5.CrossRefPubMed
3.
go back to reference Kirkels J, De Jonge N, Klöpping C, et al. Heart transplantation in the Netherlands: quo vadis? Neth Heart J. 2006;14:425–30.PubMedPubMedCentral Kirkels J, De Jonge N, Klöpping C, et al. Heart transplantation in the Netherlands: quo vadis? Neth Heart J. 2006;14:425–30.PubMedPubMedCentral
4.
go back to reference Stewart S, Winters G. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant. 2005;24:1710–20.CrossRefPubMed Stewart S, Winters G. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant. 2005;24:1710–20.CrossRefPubMed
5.
go back to reference Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435–43.CrossRefPubMed Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435–43.CrossRefPubMed
6.
go back to reference Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241–51.CrossRefPubMed Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241–51.CrossRefPubMed
8.
go back to reference Aaronson KD, Schwartz JS, Chen TM, et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997;95:2660–7.CrossRefPubMed Aaronson KD, Schwartz JS, Chen TM, et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997;95:2660–7.CrossRefPubMed
9.
go back to reference Levy WC, Mozaffarian D, Linker DT, et al. The Seattle heart failure model: prediction of survival in heart failure. Circulation. 2006;113:1424–33.CrossRefPubMed Levy WC, Mozaffarian D, Linker DT, et al. The Seattle heart failure model: prediction of survival in heart failure. Circulation. 2006;113:1424–33.CrossRefPubMed
10.
go back to reference Zijlstra LE, Constantinescu AA, Manintveld O, et al. Improved long-term survival in Dutch heart transplant patients despite increasing donor age: the Rotterdam experience. Transpl Int. 2015;28:962–71.CrossRefPubMed Zijlstra LE, Constantinescu AA, Manintveld O, et al. Improved long-term survival in Dutch heart transplant patients despite increasing donor age: the Rotterdam experience. Transpl Int. 2015;28:962–71.CrossRefPubMed
11.
go back to reference Rodriguez Cetina Biefer H, Sündermann SH, Emmert MY, et al. Surviving 20 years after heart transplantation: a success story. Ann Thorac Surg. 2014;97:499–505.CrossRefPubMed Rodriguez Cetina Biefer H, Sündermann SH, Emmert MY, et al. Surviving 20 years after heart transplantation: a success story. Ann Thorac Surg. 2014;97:499–505.CrossRefPubMed
12.
go back to reference Dellgren G, Geiran O, Lemström K, et al. Three decades of heart transplantation in Scandinavia: long-term follow-up. Eur J Heart Fail. 2013;15:308–15.CrossRefPubMed Dellgren G, Geiran O, Lemström K, et al. Three decades of heart transplantation in Scandinavia: long-term follow-up. Eur J Heart Fail. 2013;15:308–15.CrossRefPubMed
13.
go back to reference Ozduran V, Yamani MH, Chuang HH, et al. Survival beyond 10 years following heart transplantation: The Cleveland Clinic Foundation experience. Transpl Proc. 2005;37:4509–12.CrossRef Ozduran V, Yamani MH, Chuang HH, et al. Survival beyond 10 years following heart transplantation: The Cleveland Clinic Foundation experience. Transpl Proc. 2005;37:4509–12.CrossRef
14.
go back to reference Bruschi G, Colombo T, Oliva F, et al. Heart transplantation: 25 years’ single-centre experience. J Cardiovasc Med (Hagerstown). 2013;14:637–47.CrossRef Bruschi G, Colombo T, Oliva F, et al. Heart transplantation: 25 years’ single-centre experience. J Cardiovasc Med (Hagerstown). 2013;14:637–47.CrossRef
15.
go back to reference Roig E, Almenar L, Crespo-Leiro M, et al. Heart transplantation using allografts from older donors: multicenter study results. J Heart Lung Transplant. 2015;34:790–6.CrossRefPubMed Roig E, Almenar L, Crespo-Leiro M, et al. Heart transplantation using allografts from older donors: multicenter study results. J Heart Lung Transplant. 2015;34:790–6.CrossRefPubMed
16.
17.
go back to reference Lok SI, Schipper MEI, De Jonge N, et al. Two young women with soft tissue tumours of the heart. Eur J Cardiothorac Surg. 2014;45:193–6.CrossRefPubMed Lok SI, Schipper MEI, De Jonge N, et al. Two young women with soft tissue tumours of the heart. Eur J Cardiothorac Surg. 2014;45:193–6.CrossRefPubMed
18.
go back to reference Pruijsten RV, Lok SI, Kirkels JH, et al. Functional and haemodynamic recovery after implantation of continuous-flow left ventricular assist devices in comparison with pulsatile left ventricular assist devices in patients with end-stage heart failure. Eur J Heart Fail. 2012;14:319–25.CrossRefPubMed Pruijsten RV, Lok SI, Kirkels JH, et al. Functional and haemodynamic recovery after implantation of continuous-flow left ventricular assist devices in comparison with pulsatile left ventricular assist devices in patients with end-stage heart failure. Eur J Heart Fail. 2012;14:319–25.CrossRefPubMed
19.
go back to reference Brouwers C, De Jonge N, Caliskan K, et al. Predictors of changes in health status between and within patients 12 months post left ventricular assist device implantation. Eur J Heart Fail. 2014;16:566–73.CrossRefPubMed Brouwers C, De Jonge N, Caliskan K, et al. Predictors of changes in health status between and within patients 12 months post left ventricular assist device implantation. Eur J Heart Fail. 2014;16:566–73.CrossRefPubMed
Metadata
Title
Thirty years of heart transplantation at the University Medical Centre Utrecht
Authors
A. Sammani
A. M. Wind
J. H. Kirkels
C. Klöpping
M. P. Buijsrogge
F. Z. Ramjakhan
F. W. Asselbergs
N. de Jonge
Publication date
01-09-2017
Publisher
Bohn Stafleu van Loghum
Published in
Netherlands Heart Journal / Issue 9/2017
Print ISSN: 1568-5888
Electronic ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-017-0969-0

Other articles of this Issue 9/2017

Netherlands Heart Journal 9/2017 Go to the issue